Alunbrig

Alunbrig (Brigatinib) is an oral medication used to treat certain types of cancer. This guide provides key details about its uses, effects, and precautions.

Alunbrig is primarily used in the treatment of non-small cell lung cancer (NSCLC). It is often prescribed for patients with specific genetic mutations who have progressed after other treatments. The medication works by targeting and inhibiting certain proteins involved in cancer cell growth. Patients and healthcare providers often discuss 'what is Alunbrig used for' in the context of advanced or metastatic NSCLC.

Common effects of Alunbrig may include nausea, fatigue, and cough. Some users also report diarrhea and increased blood pressure. These effects can vary in intensity and duration. It's important to monitor any persistent or severe symptoms and consult a healthcare professional.

Alunbrig should be handled with care, following the guidance of a healthcare provider. It is essential to inform your doctor about any pre-existing conditions or other medications you are taking. Pregnant women or those planning to become pregnant should discuss the risks and benefits with their healthcare provider.

Alunbrig may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is advisable to avoid grapefruit and grapefruit juice, as they can affect how the body processes the medication. Always consult a healthcare provider before starting or stopping any medication while taking Alunbrig.